Skip to main content

Table 1 PSO PROMs content and the patient results coded across red, yellow, and green outcomes

From: Can patient-reported outcome measures be used to predict consultation needs in patients with psoriasis?: A survey study

PSO PROMs content    
  Red Yellow Green
  n (%) n (%) n (%)
DLQI
(Dermatology Life Quality Index)
26 (13,9) 50 (26,7) 111 (59,4)
PSSD sign
(Psoriasis Sign Score)
7 (3,7) 33 (17,6) 147 (78,6)
PSSD symptom
(Psoriasis Symptom Score)
5 (2,7) 29 (15,5) 153 (81,8)
BSA*
(Body Surface Area)
- - -
MDI-2
(Major Depression Inventory)
32 (17,1) 20 (10,7) 135 (72,2)
PEST
(Psoriasis Epidemiology Screening Tool)
21 (11,2) 16 (8,6) 150 (80,2)
Joint pain
(Do you have joint pain?)
104 (55,6) 83 (44,4)
Psoriasis arthritis
(Are you diagnosed with psoriasis arthritis?)
47 (25,1) 140 (74,9)
General well-being of psoriasis
(How are your general well-being in regard to psoriasis?)
70 (37,4) 117 (62,6)
Cardiovascular screening
(Have you had screening for cardiovascular risk factors within the last year (BG, BP, BL)?)
63 (33,7) 50 (26,7) 74 (39,6)
Side effects
(Do you have side effects to the medicine?)
39 (20,9) 24 (12,8) 124 (66,3)
  1. *BSA does not have a clear cut-off point. Mean score was calculated to 5,8 (range 0–61)